Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1756.75 | 459 / 459 | 100% | 13.66 | 1118 / 1118 |
lung | 100% | 2485.99 | 578 / 578 | 100% | 17.48 | 1155 / 1155 |
ovary | 100% | 2110.65 | 180 / 180 | 100% | 14.91 | 430 / 430 |
pancreas | 100% | 1517.47 | 328 / 328 | 100% | 13.88 | 178 / 178 |
uterus | 100% | 1436.66 | 170 / 170 | 100% | 19.57 | 459 / 459 |
esophagus | 100% | 1177.73 | 1444 / 1445 | 100% | 16.02 | 183 / 183 |
prostate | 100% | 1671.74 | 245 / 245 | 100% | 10.24 | 500 / 502 |
thymus | 100% | 1746.16 | 653 / 653 | 100% | 18.90 | 602 / 605 |
bladder | 100% | 1824.76 | 21 / 21 | 99% | 15.15 | 500 / 504 |
intestine | 100% | 1400.91 | 966 / 966 | 99% | 12.33 | 522 / 527 |
stomach | 100% | 1093.59 | 359 / 359 | 98% | 11.88 | 281 / 286 |
kidney | 100% | 1380.52 | 89 / 89 | 98% | 8.75 | 879 / 901 |
brain | 97% | 961.95 | 2574 / 2642 | 99% | 7.66 | 698 / 705 |
skin | 100% | 1798.23 | 1809 / 1809 | 95% | 10.57 | 447 / 472 |
adrenal gland | 100% | 1335.54 | 258 / 258 | 94% | 7.11 | 216 / 230 |
liver | 100% | 1334.65 | 226 / 226 | 90% | 7.30 | 365 / 406 |
adipose | 100% | 1782.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.10 | 29 / 29 |
spleen | 100% | 2536.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.42 | 1 / 1 |
blood vessel | 100% | 1351.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 778.33 | 796 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1736.53 | 913 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 759.01 | 813 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 7.93 | 64 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042532 | Biological process | negative regulation of tyrosine phosphorylation of STAT protein |
GO_0060334 | Biological process | regulation of type II interferon-mediated signaling pathway |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0070104 | Biological process | negative regulation of interleukin-6-mediated signaling pathway |
GO_0046426 | Biological process | negative regulation of receptor signaling pathway via JAK-STAT |
GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0038020 | Biological process | insulin receptor recycling |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0060336 | Biological process | negative regulation of type II interferon-mediated signaling pathway |
GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1902202 | Biological process | regulation of hepatocyte growth factor receptor signaling pathway |
GO_1902206 | Biological process | negative regulation of interleukin-2-mediated signaling pathway |
GO_1902215 | Biological process | negative regulation of interleukin-4-mediated signaling pathway |
GO_0050922 | Biological process | negative regulation of chemotaxis |
GO_0030217 | Biological process | T cell differentiation |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0045722 | Biological process | positive regulation of gluconeogenesis |
GO_1902237 | Biological process | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0045650 | Biological process | negative regulation of macrophage differentiation |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_1903899 | Biological process | positive regulation of PERK-mediated unfolded protein response |
GO_1902233 | Biological process | negative regulation of positive thymic T cell selection |
GO_1902227 | Biological process | negative regulation of macrophage colony-stimulating factor signaling pathway |
GO_0060339 | Biological process | negative regulation of type I interferon-mediated signaling pathway |
GO_0010888 | Biological process | negative regulation of lipid storage |
GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO_0030183 | Biological process | B cell differentiation |
GO_0042593 | Biological process | glucose homeostasis |
GO_2000587 | Biological process | negative regulation of platelet-derived growth factor receptor-beta signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031904 | Cellular component | endosome lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0005737 | Cellular component | cytoplasm |
GO_0004726 | Molecular function | non-membrane spanning protein tyrosine phosphatase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0097677 | Molecular function | STAT family protein binding |
GO_0005178 | Molecular function | integrin binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0019905 | Molecular function | syntaxin binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPN2 |
Protein name | Protein tyrosine phosphatase non-receptor type 2 Tyrosine-protein phosphatase non-receptor type (EC 3.1.3.48) protein-tyrosine-phosphatase (EC 3.1.3.48) Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) |
Synonyms | hCG_1999834 PTPT PTN2 |
Description | FUNCTION: Non-receptor type tyrosine-specific phosphatase that dephosphorylates receptor protein tyrosine kinases including INSR, EGFR, CSF1R, PDGFR. Also dephosphorylates non-receptor protein tyrosine kinases like JAK1, JAK2, JAK3, Src family kinases, STAT1, STAT3 and STAT6 either in the nucleus or the cytoplasm. Negatively regulates numerous signaling pathways and biological processes like hematopoiesis, inflammatory response, cell proliferation and differentiation, and glucose homeostasis. Plays a multifaceted and important role in the development of the immune system. Functions in T-cell receptor signaling through dephosphorylation of FYN and LCK to control T-cells differentiation and activation. Dephosphorylates CSF1R, negatively regulating its downstream signaling and macrophage differentiation. Negatively regulates cytokine (IL2/interleukin-2 and interferon)-mediated signaling through dephosphorylation of the cytoplasmic kinases JAK1, JAK3 and their substrate STAT1, that propagate signaling downstream of the cytokine receptors. Also regulates the IL6/interleukin-6 and IL4/interleukin-4 cytokine signaling through dephosphorylation of STAT3 and STAT6 respectively. In addition to the immune system, it is involved in anchorage-dependent, negative regulation of EGF-stimulated cell growth. Activated by the integrin ITGA1/ITGB1, it dephosphorylates EGFR and negatively regulates EGF signaling. Dephosphorylates PDGFRB and negatively regulates platelet-derived growth factor receptor-beta signaling pathway and therefore cell proliferation. Negatively regulates tumor necrosis factor-mediated signaling downstream via MAPK through SRC dephosphorylation. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of the hepatocyte growth factor receptor MET. Also plays an important role in glucose homeostasis. For instance, negatively regulates the insulin receptor signaling pathway through the dephosphorylation of INSR and control gluconeogenesis and liver glucose production through negative regulation of the IL6 signaling pathways. May also bind DNA. . |
Accessions | ENST00000591305.5 ENST00000585666.5 ENST00000645816.1 K7EIY0 D3DUJ3 ENST00000309660.10 [P17706-1] ENST00000589216.1 ENST00000327283.7 [P17706-2] A8K3N4 ENST00000587703.5 ENST00000592776.1 ENST00000591115.5 [P17706-4] K7ERU1 K7EIE9 P17706 ENST00000592059.5 ENST00000591901.5 ENST00000591497.5 ENST00000646492.1 K7ENP9 K7EQG9 K7ELS9 A0A2R8YD79 ENST00000645191.1 K7ER87 ENST00000353319.8 [P17706-3] |